Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current Opinion in Rheumatology|July 15, 2024
Antimelanoma differentiation antigen 5-positive dermatomyositis: an updateXin Lu, Qinglin Peng, Guochun WangCurrent Opinion in Rheumatology|August 2, 2019
The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndromeXin Lu, Qinglin Peng, Guochun WangCurrent Opinion in Rheumatology|September 9, 2022
Biomarkers of disease activity in dermatomyositisXin Lu, Qinglin Peng, Guochun WangClinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 2015
Discovery of new biomarkers of idiopathic inflammatory myopathyXin Lu, Qinglin Peng, Guochun WangNature Reviews. Rheumatology|December 6, 2023
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progressXin Lu, Qinglin Peng, Guochun WangPlos One|August 19, 2016
HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung DiseaseXiaoming Shu, Qinglin Peng, Xin Lu, et al.Modern Rheumatology|May 13, 2016
Abnormally increased low-density granulocytes in peripheral blood mononuclear cells are associated with interstitial lung disease in dermatomyositisSigong Zhang, Haili Shen, Xiaoming Shu, et al.Scientific Reports|March 17, 2017
Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohortsYongpeng Ge, Xin Lu, Xiaoming Shu, et al.Plos One|October 29, 2015
Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory MyopathiesYongpeng Ge, Xin Lu, Qinglin Peng, et al.CNS Neuroscience & Therapeutics|May 15, 2026
Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent AdvancesChang Gao, Wenli Li, Qingyan Liu, et al.Pageof 7